MINNEAPOLIS, July 12, 2016 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced that Darin Hammers has been appointed President and Chief Executive Officer. Mr. Hammers was also appointed to the Board of Directors of Cogentix. Mr. Hammers had been appointed interim President and Chief Executive Officer in May.
"Under Darin's leadership, Cogentix has continued its strong momentum in the marketplace and his team has been laying the strategic groundwork for our next phase of growth," said Howard Zauberman, Chairman of the Board of Cogentix Medical. "The entire Board of Directors has been impressed by the smooth leadership transition as well as the continuity in the organization Darin has inspired. His deep experience with the urology marketplace provides a significant added perspective as we focus on growth as well as increasing shareholder returns."
"Cogentix is successfully meeting several challenges this year and I am honored by the Board's confidence. I look forward to continuing to work with the entire team to build on our strong foundation and capitalize on our organic and business development growth opportunities," said Mr. Hammers.
Mr. Hammers' experience includes over 25 years of increasing leadership roles in urology sales. He joined Cogentix Medical predecessor company Uroplasty as Vice President of Global Sales in January 2013 and was promoted to Senior Vice President of Global Sales & Marketing in August 2013. In January 2016 he was promoted to Chief Operating Officer prior to being named interim President and CEO in May. Prior to joining Uroplasty, Mr. Hammers was Vice President of Sales for Bard Medical Division of C.R. Bard based in Covington, GA, focused on Urology care products. Prior to that, Mr. Hammers spent more than 12 years with Boston Scientific in various sales leadership positions in the Urology/Gynecology areas. Mr. Hammers holds a BS in Marketing from the University of Southern Indiana and an MBA from Emory University.
About Cogentix Medical
Cogentix Medical, Inc., headquartered in Minnetonka, Minnesota, with additional operations in New York, Massachusetts, The Netherlands and the United Kingdom, is a global medical device company. We design, develop, manufacture and market products for flexible endoscopy with our unique product lines featuring a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. We also commercialize the Urgent® PC Neuromodulation System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). OAB is a chronic condition that affects approximately 42 million U.S. adults. The symptoms include urinary urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on Cogentix Medical and our products, please visit us at www.cogentixmedical.com. 'CGNT-G'
For Further Information:
Cogentix Medical, Inc.
Brett Reynolds, SVP and CFO
Doug Sherk/Brian Moore (Investors)
SOURCE Cogentix Medical, Inc.